文献速递关节外科

ATTUNE全膝关节置换术骨水泥型原始设计后放射透亮线发生率高

High rate of radiolucent lines following the cemented original design of the ATTUNE total knee arthroplasty.
PubMed 文献 · Bone Joint J · 2023-06-01

该系统评价与Meta分析纳入12项研究共3861例全膝关节置换术,评估骨水泥型ATTUNE原始设计假体放射透亮线发生率及其与松动的关系。Meta分析显示总体胫骨或股骨放射透亮线发生率为21.4%(95%CI 12.7%至33.7%),ATTUNE与其他假体相比总体放射透亮线风险显著更高(OR 2.841,95%CI 1.219至6.623,p=0.016)。松动率和因松动翻修率分别为1.2%和0.9%,但研究间变异较大,作者建议对使用原始ATTUNE系统的患者密切监测。

要点

  • 骨水泥型ATTUNE原始设计总体胫骨或股骨放射透亮线发生率为21.4%(95%CI 12.7%至33.7%)。
  • ATTUNE与其他假体相比总体放射透亮线风险显著更高(OR 2.841,95%CI 1.219至6.623,p=0.016)。
  • 松动率和因松动翻修率分别为1.2%和0.9%,但研究间变异较大,临床意义不确定。

核心结论

  • 骨水泥型ATTUNE原始设计全膝关节置换术放射透亮线发生率高,但其临床意义因相关松动和翻修率总体较低而不确定。
  • 鉴于放射透亮线发生率高且研究间和登记系统间松动及翻修率存在变异,作者建议对使用原始ATTUNE系统行全膝关节置换术的患者进行密切监测。

研究设计与样本

  • 采用Cochrane方法学在MEDLINE、Embase和CINAHL三个在线数据库进行系统检索,并按预定标准筛选文献和提取数据。
  • 同时筛选欧洲骨科登记网络(Network of Orthopaedic Registries of Europe)中可用的国家关节登记系统。
  • 共纳入12项研究、3861例全膝关节置换术,并进行随机效应模型Meta分析。

主要发现

  • 10项研究的Meta分析显示骨水泥型ATTUNE原始设计总体胫骨或股骨放射透亮线发生率高,所有设计类型总体发生率为21.4%(95%CI 12.7%至33.7%)。
  • 后交叉韧带保留型亚组放射透亮线发生率为27.4%(95%CI 13.4%至47.9%),固定平台型亚组为29.9%(95%CI 15.6%至49.6%)。
  • 5项研究比较ATTUNE与其他假体,ATTUNE总体胫骨或股骨放射透亮线风险显著更高(OR 2.841,95%CI 1.219至6.623;p=0.016)。
  • 松动率和因松动翻修率分别为1.2%和0.9%,但发生率范围为0%至16.3%。
  • 登记系统数据未专门报告原始ATTUNE全膝关节置换术或因松动翻修,但骨水泥型ATTUNE全因五年翻修率范围为2.6%至5.9%。

关键数值与推荐

  • 骨水泥型ATTUNE原始设计所有类型总体胫骨或股骨放射透亮线发生率为21.4%(95%CI 12.7%至33.7%)。
  • 后交叉韧带保留型放射透亮线发生率为27.4%(95%CI 13.4%至47.9%)。
  • 固定平台型放射透亮线发生率为29.9%(95%CI 15.6%至49.6%)。
  • ATTUNE与其他假体比较总体胫骨或股骨放射透亮线的OR为2.841(95%CI 1.219至6.623;p=0.016)。
  • 松动率为1.2%,因松动翻修率为0.9%,发生率范围为0%至16.3%;骨水泥型ATTUNE全因五年翻修率范围为2.6%至5.9%。

临床怎么用

  • 作者建议对使用原始ATTUNE系统行全膝关节置换术的患者进行密切监测。

局限性

  • 放射透亮线的临床意义不确定,因为相关松动和翻修率总体较低。
  • 松动和翻修率在研究间和登记系统间存在变异。
  • 登记系统数据未专门报告原始ATTUNE全膝关节置换术或因松动翻修。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Loosening of components after total knee arthroplasty (TKA) can be associated with the development of radiolucent lines (RLLs). The aim of this study was to assess the rate of formation of RLLs in the cemented original design of the ATTUNE TKA and their relationship to loosening. METHODS: A systematic search was undertaken using the Cochrane methodology in three online databases: MEDLINE, Embase, and CINAHL. Studies were screened against predetermined criteria, and data were extracted. Available National Joint Registries in the Network of Orthopaedic Registries of Europe were also screened. A random effects model meta-analysis was undertaken. RESULTS: Of 263 studies, 12 were included with a total of 3,861 TKAs. Meta-analysis of ten studies showed high rates of overall tibial or femoral RLLs for the cemented original design of the ATTUNE TKA. The overall rate was 21.4% (95% confidence interval (CI) 12.7% to 33.7%) for all types of design but was higher for certain subgroups: 27.4% (95% CI 13.4% to 47.9%) for the cruciate-retaining type, and 29.9% (95% CI 15.6% to 49.6%) for the fixed-bearing type. Meta-analysis of five studies comparing the ATTUNE TKA with other implants showed a significantly higher risk of overall tibial or femoral RLLs (odds ratio (OR) 2.841 (95% CI 1.219 to 6.623); p = 0.016) for the ATTUNE. The rates of loosening or revision for loosening were lower, at 1.2% and 0.9% respectively, but the rates varied from 0% to 16.3%. The registry data did not report specifically on the original ATTUNE TKA or on revision due to loosening, but 'all-cause' five-year revision rates for the cemented ATTUNE varied from 2.6% to 5.9%. CONCLUSION: The original cemented ATTUNE TKA has high rates of RLLs, but their clinical significance is uncertain given the overall low associated rates of loosening and revision. However, in view of the high rates of RLLs and the variation in the rates of loosening and revision between studies and registries, close surveillance of patients who have undergone TKA with the original ATTUNE system is recommended.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Prodromidis AD, Chloros GD, Thivaios GC, et al. High rate of radiolucent lines following the cemented original design of the ATTUNE total knee arthroplasty. Bone Joint J. 2023. PMID: 37259548. doi:10.1302/0301-620X.105B6.BJJ-2022-0675.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。